Stratis Gayner Among the First To Offer DAXXIFY™

Stratis and Gayner Plastic Surgery

Harrisburg, Pennsylvania (January 2023) —Based on clinical trial data gathered from more than 2,700 patients, the FDA approved DAXXIFY in September 2022 for use on moderate-to-severe frown lines. Manufactured by Revance, DAXXIFY is a neuromodulator in the same class as BOTOX and DYSPORT® and is widely considered the first significant BOTOX rival to appear in years.

Dr. Gayner of Statis Gayner Plastic Surgery is one of the few doctors in the country offering this innovative new treatment.

Botulinum toxin type A is the main component in DAXXIFY and other neuromodulators. These treatments temporarily suppress the nerve signals that cause muscles to contract. The targeted muscles relax, reducing the appearance of dynamic wrinkles and furrows caused by repetitive facial muscle movements.

Clinical research showed that DAXXIFY delivers longer-lasting results than other neuromodulators. Most BOTOX patients experience improvement for up to 4 months following treatment. DAXXIFY, however, has been shown to produce results that last 6 months, with some individuals reporting results lasting as long as 9 months.

In addition to its long-lasting effects, DAXXIFY is distinctive as the only treatment in its class formulated with a novel peptide. Other neuromodulators contain a substance known as human serum albumin. DAXXIFY is free of human serum albumen and animal-based components.

“Clinical trials have shown that DAXXIFY is effective, safe, and well tolerated and that it can produce year-long outcomes with as few as two treatments annually,” says Dr. Gayner.

Dr. Gayner’s expertise with neuromodulator treatments is well established. A board-certified facial plastic surgeon, Dr. Gayner is the only doctor in the Central Pennsylvania region to achieve BOTOX Platinum Plus provider accreditation. This prestigious designation recognizes Dr. Gayner’s significant knowledge and experience administering these treatments.

Additionally, Dr. Gayner serves as a trainer for Allergan, the developer of BOTOX and the dermal fillers JUVÉDERM VOLUMA® and VOLBELLA. He assists other physicians in his region with methods to maximize cosmetic outcomes and patient safety when using the company’s injectables.

Cosmetic injections typically cause little or no discomfort for patients. Anesthesia isn’t necessary, but a cold pack can be used to numb the treatment area if desired.

DAXXIFY treatment takes as little as 10 minutes.

Initial results typically appear within 1 or 2 days of treatment. Improvements continue gradually over about 4 weeks.

Dr. Gayner advises anyone considering injectable cosmetic treatments to select a skilled, board-certified plastic surgeon for optimal results. “Patients are most likely to receive attractive, natural-looking results when a knowledgeable, experienced physician administers the injections.”

To learn more about DAXXIFY and other injectable anti-aging treatments, request a consultation with Dr. Gayner using the online form or call our office at (717) 728-1700.

Back to Top